Publications by authors named "Samuel D Vasikaran"

Claim this Profile
T
The importance of laboratory medicine in the management of CKD-MBD: insights from the KDIGO 2023 controversies conference.
Samuel D Vasikaran, Konstantinos Makris, Harjit Pal Bhattoa, Tomáš Zima, Pierre Delanaye

Clin Chem Lab Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of measurement uncertainty of immunoassays and LC-MS/MS methods for serum 25-hydroxyvitamin D.
Etienne Cavalier, Harjit P Bhattoa, Annemieke C Heijboer, Giovanni Lombardi, Vincent Delatour, Samuel D Vasikaran

Clin Chem Lab Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current perspectives on biomarkers in metabolic bone disease.
Samuel D Vasikaran

Curr Opin Endocrinol Diabetes Obes· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for the correct use of the nomenclature of biochemical indices of bone status: a position statement of the Joint IOF Working Group and IFCC Committee on Bone Metabolism.
Giovanni Lombardi, Niklas Rye Jørgensen, Nicholas C Harvey, Eugene V McCloskey, Kristina E Åkesson, Samuel D Vasikaran

Clin Chem Lab Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practices and Insights for Diabetes Mellitus Testing in Sri Lanka, Singapore and the Philippines.
Indika Deepani Siriwardhana, Tan Jun Guan, Maria Ruth Pineda-Cortel, Samuel D Vasikaran, Mithu Banerjee

EJIFCC· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of the nomenclature of bone status indices: a milestone in diagnostic consistency and clarity.
Etienne Cavalier, Richard Pikner, Samuel D Vasikaran, Harjit Pal Bhattoa, Konstantinos Makris

Osteoporos Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in assessment and treatment of bone, mineral and parathyroid disorders.
Samuel D Vasikaran

Curr Opin Endocrinol Diabetes Obes· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Adrenal Vein Sampling Outcomes Study (AVOS): success rates following adrenalectomy for unilateral primary aldosteronism.
Nicola Sawyer, Paul Glendenning, Samuel D Vasikaran, Michael M Page, Greg van Schie

Pathology· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Considerations for the Clinical Application of Bone Turnover Markers in Osteoporosis.
Samuel D Vasikaran, Masakazu Miura, Richard Pikner, Harjit P Bhattoa, Etienne Cavalier

Calcif Tissue Int· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current use of bone turnover markers in the management of osteoporosis.
Jacques P Brown, Andrew Don-Wauchope, Pierre Douville, Caroline Albert, Samuel D Vasikaran

Clin Biochem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein - A position paper from the IFCC Committee on bone metabolism.
Konstantinos Makris, Harjit P Bhattoa, Etienne Cavalier, Karen Phinney, Christopher T Sempos, Samuel D Vasikaran

Clin Chim Acta· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood.
Harjit P Bhattoa, Etienne Cavalier, Richard Eastell, Annemieke C Heijboer, Niklas R Jørgensen, Samuel D Vasikaran

Clin Chim Acta· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of PINP in Diagnosis and Management of Metabolic Bone Disease.
Melissa J Gillett, Samuel D Vasikaran, Charles A Inderjeeth

Clin Biochem Rev· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short- and long-term biological variation of cardiac troponin I in healthy individuals, and patients with end-stage renal failure requiring haemodialysis or cardiomyopathy.
Nick S R Lan, Lan T Nguyen, Samuel D Vasikaran, Catherine Wilson, Jacqueline Jonsson

Clin Chem Lab Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement and Clinical Utility of βCTX in Serum and Plasma.
Stephen A P Chubb, Samuel D Vasikaran

Adv Clin Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Sensitivity Cardiac Troponin I Improves Cardiovascular Risk Prediction in Older Men: HIMS (The Health in Men Study).
Nick S R Lan, Damon A Bell, Kieran A McCaul, Samuel D Vasikaran, Bu B Yeap

J Am Heart Assoc· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved technical success and radiation safety of adrenal vein sampling using rapid, semi-quantitative point-of-care cortisol measurement.
Michael M Page, Mario Taranto, Duncan Ramsay, Greg van Schie, Paul Glendenning, Samuel D Vasikaran

Ann Clin Biochem· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faecal Calprotectin.
Wpn Ganga W Pathirana, Sa Paul Chubb, Melissa J Gillett, Samuel D Vasikaran

Clin Biochem Rev· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility and Measurement of Procalcitonin.
Intan Samsudin, Samuel D Vasikaran

Clin Biochem Rev· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone turnover markers: Defining a therapeutic target.
S A Paul Chubb, Elizabeth Byrnes, Laurens Manning, Jonathan Golledge, Peter R Ebeling, Samuel D Vasikaran

Clin Biochem· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
25-Hydroxyvitamin D C3-epimer is universally present in neonatal Western Australian samples but is unlikely to contribute to diagnostic misclassification.
David J Cooke, Brian R Cooke, Damon A Bell, Samuel D Vasikaran, Paul Glendenning

Ann Clin Biochem· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis.
Samuel D Vasikaran, S A Paul Chubb

Endocrine· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is vitamin D testing at a tertiary referral hospital consistent with guideline recommendations?
Katherine Norton, Samuel D Vasikaran, Gerard T Chew, Paul Glendenning

Pathology· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of results from commercial assays for plasma CTX: The need for harmonization.
S A Paul Chubb, Christine D Mandelt, Samuel D Vasikaran

Clin Biochem· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonised Australian Reference Intervals for Serum PINP and CTX in Adults.
Samuel D Vasikaran, Sa Paul Chubb, Peter R Ebeling, Nicole Jenkins, Graham Rd Jones

Clin Biochem Rev· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis